Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye

Cutan Ocul Toxicol. 2021 Dec;40(4):350-358. doi: 10.1080/15569527.2021.1973022. Epub 2021 Sep 8.

Abstract

Purpose: To investigate the efficacy of topical application of 3% diquafosol sodium (DQS) and tocopherol (TCP) acetate mixtures in a mouse model of experimental dry eye (EDE).

Methods: After exposure to desiccating stress for 5 days, eye drops consisting of 3% DQS alone, 0.01% TCP alone, or 3% DQS and 0.005% or 0.01% TCP mixture were applied for the treatment of EDE. Tear volume, tear film break-up time (TBUT), corneal fluorescein staining scores (CFSS), and tear film lipid layer grades (TFLLG) were measured at 0, 5 and 10 days after treatment. The 2',7'-dichlorodihydrofluorescein diacetate assay (DCFDA) for reactive oxygen species (ROS) production, enzyme-linked immunosorbent assay (ELISA) for malondialdehyde (MDA), and flow cytometry for CD4 + interferon (IFN)-γ+ T cells were evaluated on the ocular surface at 10 days after treatment. In addition, levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and chemokine CC motif ligand 4 (CCL4) in the conjunctiva were measured using a multiplex immunobead assay, and conjunctival goblet cells were counted by periodic acid-Schiff staining at 10 days after treatment.

Results: Both the TCP mixture groups indicated a significant improvement in TBUT, ROS production, and MDA concentrations compared to those in the DQS alone group. Furthermore, the 0.01% TCP mixture group also showed higher tear film lipid layer grades and conjunctival goblet cell density and lower corneal fluorescein staining scores, number of CD4 + IFN-γ+ T cells, and levels of TNF-α, IL-1β, and CCL4 than the DQS alone group (P < 0.05).

Conclusions: Application of eye drops containing the mixture of DQS and TCP could stabilize the tear film lipid layer, improve TBUT and corneal epithelial damages, decrease ROS production, inflammatory molecules, and T cells, and increase conjunctival goblet cell density on the ocular surface. Topical DQS and TCP mixtures may have a greater therapeutic effect on clinical signs, oxidative damage, and inflammation of dry eye than DQS eye drops.

Keywords: Dry eye; diquafosol sodium; lipid layer; oxidative damage; tocopherol.

MeSH terms

  • Administration, Ophthalmic
  • Animals
  • Conjunctiva / drug effects
  • Conjunctiva / pathology
  • Cornea / drug effects
  • Cornea / pathology
  • Disease Models, Animal
  • Drug Combinations
  • Dry Eye Syndromes / drug therapy*
  • Dry Eye Syndromes / pathology
  • Female
  • Humans
  • Mice
  • Ophthalmic Solutions / administration & dosage*
  • Polyphosphates / administration & dosage*
  • Tears / drug effects
  • Tears / metabolism
  • Uracil Nucleotides / administration & dosage*
  • alpha-Tocopherol / administration & dosage*

Substances

  • Drug Combinations
  • Ophthalmic Solutions
  • Polyphosphates
  • Uracil Nucleotides
  • diquafosol
  • alpha-Tocopherol